TSTickerStar
Company alerts/HIMS
HIMS company alerts

HIMS updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for HIMS. Subscribe to HIMS alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent HIMS alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

EarningsOfficial company source

HIMS Q3 2026 Revenue $890.373 million, Beat Guidance by +$0.4M

HIMS beat prior Q3 2026 Revenue guidance by +$0.4M. Revenue was raised by +$30.0M to $3.13 billion-$3.15 billion (midpoint $3.14 billion). Revenue increased 49% year over year, but gross margin declined to 57% from 74% and the company reported a $33.040 million net loss versus $15.774 million of net income a year earlier. FY 2026 revenue guidance was tightened to $3.13 billion-$3.15 billion from $3.1 billion-$3.3 billion, with the midpoint $60 million lower, while Adjusted EBITDA guidance was reduced to $257-$27...

Read source-backed brief
SEC filingSEC filing

HIMS 10-Q filed 2026-11-09 | Key takeaways

HIMS filed its 10-Q; the most relevant disclosure change is expanded Business combinations: Completed Eucalyptus acquisition in June 2026 for preliminary purchase price of $968.5M (cash of $225M, deferred payments of $683.9M, earn-out up to $96.6M); acquired YourBio Health in January 2026 for $153.0M (cash of $142.4M, earn-out of $10.6M); goodwill in.

Read source-backed brief